comparemela.com

Latest Breaking News On - Krishnan nandabalan - Page 4 : comparemela.com

Short Interest in BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Expands By 21.2%

Should You Buy or Sell BioXcel Therapeutics Stock? Get The Latest BTAI Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Massachusetts
United-states
Blackrock
Frank-yocca
Krishnan-nandabalan
Nasdaq
Jefferies-financial-group
Massachusetts-financial-services-co
Vanguard-group-inc
Driehaus-capital-management
Goldman-sachs-group
Bioxcel-therapeutics-inc

Klaytn (KLAY) Market Capitalization Tops $689.52 Million

Should You Buy or Sell BioXcel Therapeutics Stock? Get The Latest BTAI Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Switzerland
Swiss
Krishnan-nandabalan
Richardi-steinhart
Securities-exchange-commission
Nasdaq
Swiss-national-bank
Raymond-james-associates
Jpmorgan-chase-co
Jefferies-financial-group
Metlife-investment-management
York-mellon-corp

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Director Sells $1,039,200.00 in Stock

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) Director Krishnan Nandabalan sold 60,000 shares of the business’s stock in a transaction that occurred on Thursday, April 6th. The stock was sold at an average price of $17.32, for a total transaction of $1,039,200.00. The sale was disclosed in a filing with the Securities & Exchange Commission, […]

Hong-kong
Krishnan-nandabalan
Northwestern-mutual-wealth-management-co
Jefferies-financial-group
Securities-exchange-commission
Goldman-sachs-group
Bioxcel-therapeutics-inc
Hong-kong-ltd
Nasdaq
Barclays-plc
Bioxcel-therapeutics
Get-rating

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Director Sells $1,039,200.00 in Stock

BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Rating) Director Krishnan Nandabalan sold 60,000 shares of the company’s stock in a transaction on Thursday, April 6th. The shares were sold at an average price of $17.32, for a total transaction of $1,039,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which […]

Krishnan-nandabalan
Northwestern-mutual-wealth-management-co
Jefferies-financial-group
Group-plc
Nasdaq
Bioxcel-therapeutics-company-profile
Northern-trust-corp
Goldman-sachs-group
Securities-exchange-commission
Jpmorgan-chase-co
Bioxcel-therapeutics-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.